Clinical Characteristics in the Acute Phase of COVID-19 That Predict Long COVID: Tachycardia, Myalgias, Severity, and Use of Antibiotics as Main Risk Factors, While Education and Blood Group B Are Protective.

Background: Risk factors for developing long COVID are not clearly established. The present study was designed to determine if any sign, symptom, or treatment of the acute phase, or personal characteristics of the patient, is associated with the development of long COVID.

Methods: A cohort study was carried out, randomly selecting symptomatic COVID-19 patients and not vaccinated. The severity of the acute illness was assessed through the number of compatible COVID-19 symptoms, hospitalizations, and the symptom severity score using a 10-point visual analog scale.

Results: After multivariate analysis, a severity score ≥8 (RR 2.0, 95%CI 1.1-3.5, = 0.022), hospitalization (RR 2.1, 95%CI 1.0-4.4, = 0.039), myalgia (RR 1.9, 95%CI 1.08-3.6, = 0.027), tachycardia (RR 10.4, 95%CI 2.2-47.7, = 0.003), and use of antibiotics (RR 2.0, 95%CI 1.1-3.5, = 0.022), was positively associated with the risk of having long COVID. Higher levels of education (RR 0.6, 95%CI 0.4-0.9, = 0.029) and type positive B blood group (B + AB, RR 0.44, 95%CI 0.2-0.9, = 0.044) were protective factors. The most important population attributable fractions (PAFs) for long COVID were myalgia (37%), severity score ≥8 (31%), and use of antibiotics (27%).

Conclusions: Further studies in diverse populations over time are needed to expand the knowledge that could lead us to prevent and/or treat long COVID.